PMID: 6408232Jul 1, 1983Paper

Continuous therapy with sulfamethoxazole-trimethoprim in patients with chronic granulomatous disease

The Journal of Pediatrics
R S WeeningD Roos

Abstract

In a retrospective study, the effect of long-term treatment with sulfamethoxazole-trimethoprim was evaluated in nine male patients with chronic granulomatous disease. During this treatment, a marked reduction was observed in the number of infectious episodes, the number of causative agents, and the number of surgical interventions. Furthermore, a significant reduction in days of hospitalization per year was found. The mean observation period was six years before and four years during treatment. Transient alopecia was observed in one patient during therapy. We conclude that prophylactic treatment with sulfamethoxazole-trimethoprim is beneficial in patients with chronic granulomatous disease.

References

Aug 1, 1980·The Journal of Clinical Investigation·E L MillsP G Quie

❮ Previous
Next ❯

Citations

Jun 10, 1998·Springer Seminars in Immunopathology·C Meischl, D Roos
Nov 1, 1993·European Journal of Pediatrics·A FischerR S Weening
Feb 6, 2010·Pediatric Radiology·Alexander J Towbin, Ian Chaves
Oct 23, 2008·Current Allergy and Asthma Reports·Nevin W Wilson, Mary Beth Hogan
Dec 1, 1985·Current Problems in Pediatrics·L T Gutman
Nov 21, 1991·The New England Journal of Medicine·R MouyA Fischer
Jun 13, 2003·The New England Journal of Medicine·John I GallinSteven M Holland
Aug 1, 1991·Journal of Paediatrics and Child Health·Y L LauC B Chow
Oct 15, 2003·Clinical Microbiology Reviews·Timothy Andrews, Kathleen E Sullivan
Aug 16, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Claire AguilarOlivier Lortholary
Aug 21, 2015·Expert Review of Clinical Immunology·Payam MohammadinejadAsghar Aghamohammadi
Jun 1, 1987·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·D RoccatelloD Cordonnier
Jul 1, 1984·Journal of the American Academy of Dermatology·R J Coskey
Jul 1, 1984·The Journal of Pediatrics·N KamaniH W Lischner
Dec 29, 2000·Pediatric Clinics of North America·B H Segal, S M Holland
Mar 1, 1995·American Journal of Surgery·J W EckertM L Brandt
Apr 1, 1993·The Annals of Thoracic Surgery·H W PogrebniakH I Pass
Jan 26, 2008·British Journal of Haematology·Reinhard A Seger
Feb 18, 2010·Pediatrics International : Official Journal of the Japan Pediatric Society·Mizuka MikiMasao Kobayashi
Jun 27, 2002·Expert Opinion on Pharmacotherapy·David Goldblatt
Oct 26, 1999·Lancet·A MahéA Gessain
Aug 21, 2010·Clinical Pediatrics·Julie A McElroyJohn V Williams
Apr 1, 1994·Immunological Reviews·D Roos
Jan 1, 1989·Pediatric Pulmonology·J L SotomayorR W Wilmott
Apr 16, 1998·The Pediatric Infectious Disease Journal·D Kosmala, D Janner
Oct 9, 2009·Current Opinion in Allergy and Clinical Immunology·Alexandra F Freeman, Steven M Holland
Jul 9, 2003·Journal of Pediatric Hematology/oncology·Masao KobayashiKazuhiro Ueda
Feb 9, 2013·Expert Review of Clinical Immunology·Seyed Alireza MahdavianiAli Akbar Velayati
Jul 17, 2015·The Pediatric Infectious Disease Journal·Pietro BortolettoBen Z Katz
Dec 1, 2011·Obstetric Medicine·Michi HisanoKoushi Yamaguchi
Sep 30, 2000·Clinical and Experimental Immunology·D Goldblatt, A J Thrasher
May 11, 2018·Journal of the Pediatric Infectious Diseases Society·Maria A Slack, Isaac P Thomsen
Jul 10, 2020·British Journal of Haematology·Andrew R Gennery
May 1, 1992·The Journal of Urology·M M WaltherJ I Gallin
Jan 5, 2013·Ear, Nose, & Throat Journal·Jonathan K SeigelThomas H Belhorn
Nov 4, 2000·The Journal of Pediatrics·J LieseB H Belohradsky

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.